A STUDY OF THE SAFETY AND EFFECTIVENESS OF RISPERIDONE FOR THE TREATMENT OF CONDUCT DISORDER AND OTHER DISRUPTIVE BEHAVIOR DISORDERS IN CHILDREN AGES 5 TO 12 WITH MILD, MODERATE, OR BORDERLINE MENTAL RETARDATION: